Nakajima Kyoko | Department Of Frontier Medical Science School Of Medicine Fukuoka University
スポンサーリンク
概要
- NAKAJIMA Kyokoの詳細を見る
- 同名の論文著者
- Department Of Frontier Medical Science School Of Medicine Fukuoka Universityの論文著者
関連著者
-
Emoto Makoto
Department Of Obstetrics And Gynecology School Of Medicine Fukuoka University
-
CHOIJAMTS Batsuren
Department of Obstetrics and Gynecology, School of Medicine, Fukuoka University
-
Miyamoto Shingo
Department Of Allergy And Rheumatology Japanese Red Cross Medical Center Hospital
-
Miyamoto Shingo
Department Of Obstetrics And Gynecology Faculty Of Medicine Fukuoka University
-
Emoto Makoto
Department Of Obstetrics And Gynecology Faculty Of Medicine Fukuoka University
-
Emoto Makoto
Department Of Obstetrics & Gynecology Fukuoka University Medical School
-
Naganuma Yasuko
Department Of Obstetrics And Gynecology School Of Medicine Fukuoka University
-
Kawarabayashi Tatsuhiko
Department Of Obstetrics And Gymecology Fukuoka University School Of Medicine
-
Choijamts Batsuren
Department Of Obstetrics And Gynecology School Of Medicine Fukuoka University
-
Nakajima Kyoko
Department Of Frontier Medical Science School Of Medicine Fukuoka University
-
Kawarabayashi Tatsuhiko
Department Of Obstetrics And Gynecology Fukuoka University
-
Shirota Kyoko
Department Of Obstetrics And Gynecology Fukuoka University Faculty Of Medicine
-
Shirota Kyoko
Department Of Obstetrics And Gynecology Faculty Of Medicine Fukuoka University
-
Miyamoto Shingo
Department Of Obstetrics And Gynecology School Of Medicine Fukuoka University
-
Nakajima Kyoko
Joint Laboratory For Pathological Biochemistry School Of Medicine. Fukuoka University
-
Tachibana Katsuro
Department Of Anatomy Fukuoka University School Of Medicine
-
Tachibana Katsuro
Department Of Anatomy School Of Medicine Fukuoka University
-
Ogata Shigenori
Joint Laboratory For Frontier Medical Science Faculty Of Medicine Fukuoka University
著作論文
- Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft
- Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts